Argenica Therapeutics Limited (AGN.AU) Q1 2026 Earnings

9FebConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.03
0.31
0.64
0.97

Details

Expected EPS
N/A
Actual EPS
-0.027965614520250003
Surprise EPS
-0.03
Surprise Percent
+∞%

Description

Argenica Therapeutics Limited (AGN.AU) has reported earnings of -0.027965614520250003 per share for Q1 2026.

0 Comments

Share your thoughts